Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

2184 ARTÍCULOS , VIENDO DEL 1 AL 15

Melatonin and Synthetic Melatoninergic Agonists in Psychiatric and Age-associated Disorders: Successful and Unsuccessful Approaches

Hardeland R.

Curr Pharm Des. 2016;22(8):1086-101. doi: 10.2174/1381612822666151214125543.

An Update on Human Stem Cell-Based Therapy in Parkinson's Disease

González C, Bonilla S, Flores AI, Cano E, Liste I.

Curr Stem Cell Res Ther. 2016;11(7):561-8. doi: 10.2174/1574888x10666150531172612.

Synthetic and Natural Monoamine Oxidase Inhibitors as Potential Lead Compounds for Effective Therapeutics

Pathak A, Srivastava AK, Singour PK, Gouda P.

Cent Nerv Syst Agents Med Chem. 2016;16(2):81-97. doi: 10.2174/1871524915666150624120516.

Fatal Neuroleptic Malignant Syndrome Associated With Quetiapine

Schattner A, Kitroser E, Cohen JD.

Am J Ther. 2016 Sep-Oct;23(5):e1209-10. doi: 10.1097/MJT.0000000000000274.

Research Advancements in Porcine Derived Mesenchymal Stem Cells

Bharti D, Shivakumar SB, Subbarao RB, Rho GJ.

Curr Stem Cell Res Ther. 2016;11(1):78-93. doi: 10.2174/1574888x10666150723145911.

Renin-Angiotensin-Aldosterone System: A Current Drug Target for the Management of Neuropathic Pain

Muthuraman A, Kaur P.

Curr Drug Targets. 2016;17(2):178-95. doi: 10.2174/1389450116666150825115658.

Mesolimbic Dopamine and the Regulation of Motivated Behavior

Salamone JD, Pardo M, Yohn SE, López-Cruz L, SanMiguel N, Correa M.

Curr Top Behav Neurosci. 2016;27:231-57. doi: 10.1007/7854_2015_383.

Neuroprotective effects of glucose-dependent insulinotropic polypeptide in Alzheimer's disease

Ji C, Xue GF, Li G, Li D, Hölscher C.

Rev Neurosci. 2016 Jan;27(1):61-70. doi: 10.1515/revneuro-2015-0021.

The Association Between Parkinson's Disease Motor Impairments and Pain

Allen NE, Wong CM, Canning CG, Moloney N.

Pain Med. 2016 Mar;17(3):456-462. doi: 10.1111/pme.12898. Epub 2016 Feb 2.

A Recent Perspective on Discovery and Development of Diverse Therapeutic Agents Inspired from Isatin Alkaloids

Rane RA, Karunanidhi S, Jain K, Shaikh M, Hampannavar G, Karpoormath R.

Curr Top Med Chem. 2016;16(11):1262-89. doi: 10.2174/1568026615666150915112334.

Prevalence of brain and spinal cord inclusions, including dipeptide repeat proteins, in patients with the C9ORF72 hexanucleotide repeat expansion: a systematic neuropathological review

Schipper LJ, Raaphorst J, Aronica E, Baas F, de Haan R, de Visser M, Troost D.

Neuropathol Appl Neurobiol. 2016 Oct;42(6):547-60. doi: 10.1111/nan.12284.

Nitric Oxide Homeostasis in Neurodegenerative Diseases

Hannibal L.

Curr Alzheimer Res. 2016;13(2):135-49. doi: 10.2174/1567205012666150921101250.

Distress from Motivational Dis-integration: When Fundamental Motives Are Too Weak or Too Strong

Cornwell JF, Franks B, Higgins ET.

Curr Top Behav Neurosci. 2016;27:547-68. doi: 10.1007/7854_2015_389.

Comparison of Human Primary with Human iPS Cell-Derived Dopaminergic Neuron Grafts in the Rat Model for Parkinson's Disease

Peng SP, Copray S.

Stem Cell Rev Rep. 2016 Feb;12(1):105-20. doi: 10.1007/s12015-015-9623-7.

Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders

Mollenhauer B, Parnetti L, Rektorova I, Kramberger MG, Pikkarainen M, Schulz-Schaeffer WJ, Aarsland D, Svenningsson P, Farotti L, Verbeek MM, Schlossmacher MG.

J Neurochem. 2016 Oct;139 Suppl 1:290-317. doi: 10.1111/jnc.13390. Epub 2016 Feb 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias